Latest news
Loading news…
Aviceda Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2018 51-100 employees For Profit
Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
22
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 5
- IT spend
- $98K
Company Info
- Founded
- 2018
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 55
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 1.1
- Trend (30d)
- 1.2
- Trend (90d)
- -0.2
- Last leadership hire
- Apr 1, 2025
Key People at Aviceda Therapeutics
Chief Strategy Officer
Co-Founder, CEO & President, Executive Board Director
Scientific Co-Founder
22
professional contacts at Aviceda Therapeutics
Contact execs at Aviceda Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Aviceda Therapeutics
Loading news…
FAQs about Aviceda Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.